Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
26,551,442
-
Shares change
-
+5,746,372
-
Total reported value, excl. options
-
$327,060,299
-
Value change
-
+$69,901,807
-
Number of buys
-
51
-
Number of sells
-
-17
-
Price
-
$12.32
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2014
74 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q2 2014.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,551,442 shares
of 183,255,226 outstanding shares and own 14.5% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (4,919,625 shares), FRANKLIN RESOURCES INC (3,680,581 shares), Broadfin Capital, LLC (2,808,173 shares), BAKER BROS. ADVISORS LP (2,607,784 shares), Savitr Capital, LLC (1,833,614 shares), PERCEPTIVE ADVISORS LLC (1,634,555 shares), VHCP Management, LLC (1,095,734 shares), Tekla Capital Management LLC (873,940 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (779,275 shares), and Cormorant Asset Management, LLC (700,000 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.